IMAGO BIOSCIENCES
Imago BioSciences is a San Francisco-based clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose great challenges to patients, their families and their physicians. The company leverages the skills and extensive experience of its team and the financial commitment of its investors to focus on a small family of orphan diseases. Imago BioSciences translates unique insights into high impact transformative therapies that alter the natural history of disease allowing patients to live longer, disease-free lives.
IMAGO BIOSCIENCES
Industry:
Biotechnology Life Science Medical
Founded:
2012-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.imagobio.com
Total Employee:
51+
Status:
Active
Contact:
(415) 529-5055
Email Addresses:
[email protected]
Total Funding:
146.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online Organization Schema
Similar Organizations
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Farallon Capital Management
Farallon Capital Management investment in Series C - Imago BioSciences
MRL Ventures Fund
MRL Ventures Fund investment in Series C - Imago BioSciences
Xeraya Capital
Xeraya Capital investment in Series C - Imago BioSciences
Greenspring Associates
Greenspring Associates investment in Series C - Imago BioSciences
Kingdon Capital
Kingdon Capital investment in Series C - Imago BioSciences
BlackRock
BlackRock investment in Series C - Imago BioSciences
Pharmaron
Pharmaron investment in Series C - Imago BioSciences
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Imago BioSciences
Amgen Ventures
Amgen Ventures investment in Series C - Imago BioSciences
Surveyor Capital
Surveyor Capital investment in Series C - Imago BioSciences
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-23 | Imago BioSciences Appoints Michael Arenberg to Chief Operating and Business Officer |
Official Site Inspections
http://www.imagobio.com Semrush global rank: 2.13 M Semrush visits lastest month: 9.53 K
Unable to get host informations!!!
More informations about "Imago BioSciences"
Imago BioSciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number (415) 529-5055 Imago BioSciences is a clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose …See details»
Imago BioSciences Company Profile 2024: Valuation, …
Imago BioSciences General Information Description. Imago BioSciences Inc is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), …See details»
Imago BioSciences Company Profile | Management and …
Www.imagobio.com Imago BioSciences Profile and History Imago BioSciences is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product …See details»
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
Dec 12, 2022 Copies of the documents filed with the SEC by Imago may be obtained at no charge on Imago’s internet website at www.imagobio.com or by contacting Imago at 303 Twin …See details»
Imago BioSciences - Craft
Jun 10, 2022 Imago BioSciences is a clinical-stage biotechnology company developing treatments for myeloid diseases. It conducts research in bone marrow disease prevention and …See details»
Merck to Acquire Imago BioSciences, Inc. - Merck.com
Nov 21, 2022 Acquisition expands Merck’s growing hematology portfolio Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (“Imago”) …See details»
Imago BioSciences, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Imago BioSciences, Inc. of South San Francisco, CA. Get the latest business insights from Dun & …See details»
Imago BioSciences - Overview, News & Similar companies
Who is Imago BioSciences. Imago BioSciences is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysi ne …See details»
Imago BioSciences | VentureRadar
The company is currently focused on neoplastic diseases of the bone marrow including acute myeloid leukemia, myelodysplastic syndrome, polycythemia vera, myelofibrosis and essential …See details»
Imago BioSciences - Company Profile - Tracxn
Nov 7, 2024 Imago BioSciences - Developer of epigenetic-based therapies for rare genetic cancers. Acquired by Merck. Raised a total funding of $160M over 3 rounds from 18 investors. …See details»
Imago BioSciences Announces Upcoming Presentations on
May 12, 2022 The company is based in South San Francisco, California. To learn more, visit www.imagobio.com, ... difficulties in expanding our organization and managing growth, …See details»
Merck Announces $1.35 Billion Acquisition of Imago BioSciences
Nov 28, 2022 Merck, known as MSD outside of the United States and Canada, announced its intention to acquire Imago BioSciences, a clinical-stage biopharmaceutical company focused …See details»
Merck & Co. to acquire Imago BioSciences | C&EN Global Enterprise
Nov 28, 2022 It’s not Seagen but another company that Merck & Co. will acquire this year. The pharma giant will pay a total of $1.35 billion for Imago BioSciences. Merck’s acquisition of …See details»
Imago BioSciences (USA) Funding: $146.5M
Sep 15, 2024 Imago BioSciences is working on a treatment that shuts down an enzyme important to blood cancer...See details»
Merck to Acquire Imago BioSciences, Inc. | Business Wire
Nov 21, 2022 Copies of the documents filed with the SEC by Imago may be obtained at no charge on Imago’s internet website at www.imagobio.com or by contacting Imago at 303 Twin …See details»
Imago BioSciences Inc. - Cruelty Free Investing
Imago Biosciences, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing small molecule product candidates that target lysine-specific …See details»
Imago BioSciences raises $80M to advance blood cancer therapy
Nov 19, 2020 Imago hopes bomedemstat will stave off disease progression and—in the case of myelofibrosis—prevent the condition from becoming a deadlier form of cancer, acute myeloid …See details»
Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial ...
Jul 20, 2021 Matthew Plunkett, PhD Chief Financial Officer, Imago Biosciences [email protected]. Release Summary. Imago BioSciences, Inc. Announces …See details»
Imago BioSciences Announces First Participant Dosed in …
REDWOOD CITY, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical-stage biopharmaceutical company discovering and …See details»
Imago Bio - Overview, News & Competitors | ZoomInfo.com
Imago Bio - Business Information. Hospitality · France · 75 Employees. Des fruits et légumes biologiques français de qualité en direct de Multi producteurs toute l’année.Imago bio est le …See details»